Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2022-03-02 00:00:00 ET · period of report 2022-02-28 · accession 0001104659-22-029520 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-02 | 2022-02-28 | PTGX | PATEL DINESH V PH D | Pres, CEO, Dir | F - Tax | $24.28 | -4,648 | 503.8K | -0.9% | -$112.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-28 | F | D | 4,648 | $24.28 | 503,760 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 13,438 vested restricted stock units on February 28, 2022. |